Altundag, K. 2017. Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer. EJSO , vol.43, no.6 , 1142.

Altundag, K., (2017). Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer. EJSO , vol.43, no.6, 1142.

Altundag, K.. "Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer," EJSO , vol.43, no.6, 1142, 2017

Altundag, K.. "Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer." EJSO , vol.43, no.6, pp.1142, 2017

Altundag, K. (2017) . "Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer." EJSO , vol.43, no.6, p.1142.

@article{article, author={K. Altundag}, title={Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer}, journal={EJSO}, year=2017, pages={1142} }